You need JavaScript to view this

Leukemia in Nagasaki atomic bomb survivors

Technical Report:

Abstract

In the 13.5 years following the detonation of the atomic bomb, 95 cases of leukemia have been observed in the Nagasaki survivors. This increase is highly significant statistically. The increased leukemia risk apparently started 1.5 to 2.5 years following radiation exposure, and has lasted through 1958. Acute leukemias of all types and chronic granulocytic leukemia are increased, (with the possible exception of the Schilling type of acute monocytic leukemia). Males in general, and individuals in the younger ages (0 to 09), are apparently most sensitive. The risk of radiation induction of leukemia is related to the size of the dose. The shape of the curve does not differ greatly from a linear model, but is consistent with a variety of hypotheses. The data in the low dose region are too limited to be of significance in evaluating the risk of low doses of radiation. The data suggest that high radiation doses may be associated with a decrease in the latent period to leukemia induction. 43 references, 2 figures, 31 tables.
Publication Date:
Aug 01, 1960
Product Type:
Technical Report
Report Number:
ABCC-11-59
Reference Number:
EDB-84-057957
Resource Relation:
Other Information: Portions are illegible in microfiche products
Subject:
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.; A-BOMB SURVIVORS; DELAYED RADIATION EFFECTS; LEUKEMIA; RADIOINDUCTION; DATA COMPILATION; DOSE-RESPONSE RELATIONSHIPS; NAGASAKI; RADIATION HAZARDS; SEX DEPENDENCE; SURVIVAL TIME; ASIA; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; DATA; DISEASES; HAZARDS; HEALTH HAZARDS; HEMIC DISEASES; HUMAN POPULATIONS; INFORMATION; JAPAN; NEOPLASMS; NUMERICAL DATA; POPULATIONS; RADIATION EFFECTS; 560151* - Radiation Effects on Animals- Man; 560161 - Radionuclide Effects, Kinetics, & Toxicology- Man
OSTI ID:
5215243
Research Organizations:
Atomic Bomb Casualty Commission, Hiroshima (Japan)
Country of Origin:
Japan
Language:
Japanese and English
Contract Number:
AC01-76EV03081
Other Identifying Numbers:
Other: ON: DE84008427
Availability:
NTIS, PC A05/MF A01; 1.
Submitting Site:
HEDB
Size:
Pages: 78
Announcement Date:

Technical Report:

Citation Formats

Brill, A B, Heyssel, R, Itoga, T, and Tomonaga, M. Leukemia in Nagasaki atomic bomb survivors. Japan: N. p., 1960. Web.
Brill, A B, Heyssel, R, Itoga, T, & Tomonaga, M. Leukemia in Nagasaki atomic bomb survivors. Japan.
Brill, A B, Heyssel, R, Itoga, T, and Tomonaga, M. 1960. "Leukemia in Nagasaki atomic bomb survivors." Japan.
@misc{etde_5215243,
title = {Leukemia in Nagasaki atomic bomb survivors}
author = {Brill, A B, Heyssel, R, Itoga, T, and Tomonaga, M}
abstractNote = {In the 13.5 years following the detonation of the atomic bomb, 95 cases of leukemia have been observed in the Nagasaki survivors. This increase is highly significant statistically. The increased leukemia risk apparently started 1.5 to 2.5 years following radiation exposure, and has lasted through 1958. Acute leukemias of all types and chronic granulocytic leukemia are increased, (with the possible exception of the Schilling type of acute monocytic leukemia). Males in general, and individuals in the younger ages (0 to 09), are apparently most sensitive. The risk of radiation induction of leukemia is related to the size of the dose. The shape of the curve does not differ greatly from a linear model, but is consistent with a variety of hypotheses. The data in the low dose region are too limited to be of significance in evaluating the risk of low doses of radiation. The data suggest that high radiation doses may be associated with a decrease in the latent period to leukemia induction. 43 references, 2 figures, 31 tables.}
place = {Japan}
year = {1960}
month = {Aug}
}